漱玉平民大药房连锁股份有限公 司相关债券 2025 年跟踪评级报告 中鹏信评【2025】跟踪第【265】号 01 信用评级报告声明 除因本次评级事项本评级机构与评级对象构成委托关系外，本评级机构及评级从业人员与评级对象不存 在任何足以影响评级行为独立、客观、公正的关联关系。 本评级机构与评级从业人员已履行尽职调查义务，有充分理由保证所出具的评级报告遵循了真实、客 观、 公正原则，但不对评级对象及其相关方提供或已正式对外公布信息的合法性、真实性、准确性和完整性 作任何保证。 本评级机构依据内部信用评级标准和工作程序对评级结果作出独立判断，不受任何组织或个人的影响。 本评级报告观点仅为本评级机构对评级对象信用状况的个体意见，不作为购买、出售、持有任何证券的 建议。本评级机构不对任何机构或个人因使用本评级报告及评级结果而导致的任何损失负责。 本次评级结果自本评级报告所注明日期起生效，有效期为被评证券的存续期。同时，本评级机构已对受 评对象的跟踪评级事项做出了明确安排，并有权在被评证券存续期间变更信用评级。本评级机构提醒报 告使用者应及时登陆本公司网站关注被评证券信用评级的变化情况。 本评级报告版权归本评级机构所有， ...

思宇年度活动回顾： 首届全球眼科大会 | 首届全球骨科大会 | 首届全球心血管大会 | 首届全球医美科技大会 参会需付费，价格：1200元/人。 名额有限，请尽早报名～ # 报名方法 请复制以下链接至IE浏览器 或 点击文末 " 阅读原文 "报名（会有工作人员联系） https://docs.qq.com/form/page/DUFpkTmZiSHVad0JJ 或者 扫描下方二维码报名 | 主持人:刘 贞 中国医学装备协会应用评价分会秘书长 | | --- | | 09:00-09:20 领导致辞 | | 嘉宾:蔡 葵 中国医学装备协会应用评价分会会长 | | 09:20-09:50《医院新产品准入流程》 | | 嘉宾:郑蕴欣 上海市第六人民医院临港院区副院长 | | 09:50-10:20 《高质量发展下创新医疗器械在医疗机构中的准入与评估》 | | 嘉宾:张璐璐 首都医科大学附属北京友谊医院医学工程处 | | 10:20-10:50《医院物价提单流程要求》 | | 嘉宾:赖雪蕾 北京市海淀医院、北京大学海淀区医学装备科主任 | | 10:50-11:00 茶歇 | | 11:00-11:30《VBP政策介 ...

罗缵吉为本次会议任命的人员颁发任命书，新任命人员依法进行宪法宣誓。 市监察委员会、市中级人民法院、市人民检察院以及有关方面负责同志列席会议。 会议还听取市人大法制委关于《长沙市征地补偿安置若干规定(草案)》 审议结果的报告，书面听取市人 大环资委关于《长沙市征地补偿安置若干规定(草案)》审议意见的报告；听取有关人事议案的说明。 在下午举行的第二次全体会议上，听取市人大法制委关于《长沙市征地补偿安置若干规定（草案二次审 议稿）》修改意见的报告；表决通过《长沙市征地补偿安置若干规定》，待省人大常委会审查批准后， 再公布实施；表决通过了有关人事任免案。 6月20日，市十六届人大常委会举行第三十次会议，市人大常委会主任罗缵吉主持并讲话。市人大 常委会副主任曹再兴、李平、李伟群、张能峰、王瑜珲、张白云、杨长江，秘书长缪晨光参加。副市长 康镇麟列席。 在上午举行的第一次全体会议上，听取市人民政府关于全市医保基金运行管理情况的报告及市人大常委 会关于医保基金使用监督情况报告的意见和建议；听取市人民政府贯彻实施《中华人民共和国中小企业 促进法》《湖南省实施〈中华人民共和国中小企业促进法〉办法》情况报告的审议意见研究处理情况的 ...

Group 1 - The AFL-CIO report highlights that if the proposed Republican tax reform is passed, approximately 179 million Americans relying on employer-provided health insurance could face an annual premium increase of up to $485 each [1] - The Congressional Budget Office (CBO) estimates that the tax reform could cut federal Medicaid spending by nearly $800 billion over the next decade, affecting over 70 million Americans currently covered by Medicaid [1][2] - The expiration of ACA premium subsidies in 2025, as noted in the report, will lead to an increase in the uninsured population, with projections indicating that 16 million Americans could be without insurance by 2034 [2] Group 2 - The reduction in Medicaid funding is expected to significantly impact hospital operations, as Medicaid accounts for about 19% of hospital revenue in the U.S. [2] - The CBO anticipates that the increase in uninsured individuals will result in an additional $63 billion in uncompensated care costs for the healthcare system over the next decade [2] - Hospitals may face two choices in response to rising uncompensated care: either negotiate higher reimbursement rates from commercial insurers, which would increase costs for employer-sponsored insurance, or operate with reduced margins, potentially leading to closures of struggling rural hospitals [3] Group 3 - The report indicates that 40% of hospitals in the U.S. are currently operating at a loss, and further revenue constraints could exacerbate this issue, leading to reduced services and longer wait times for patients [3] - The healthcare insurance sector reacted negatively to the news, with stocks of major health insurance companies like Humana, UnitedHealth, CVS, and Cigna experiencing declines [3] - The potential implementation of the tax reform could accelerate the differentiation within the health insurance industry, negatively impacting smaller insurers while potentially strengthening the market position of larger commercial insurance giants [3]

6月20日，据国家医保局消息，目前，职工医保个人账户共济可以通过即时调用被绑定人个人账户、医 保钱包转账等方式实现。2025年1-5月职工医保个人账户共济人次1.67亿，金额220.26亿元。 ...

Core Insights - The contradiction between cost control and patient satisfaction creates significant opportunities for commercial insurance to deeply engage in the medical security system [1][3] - The medical security system in China is undergoing profound changes, driven by heightened public health awareness and rapid advancements in medical technology [2] Group 1: Current State of Medical Insurance - As of the end of 2024, the number of people covered by basic medical insurance in China is expected to reach 1.326 billion, maintaining a coverage rate of around 95% [3] - The total number of outpatient treatment cases benefiting from medical insurance has increased by 37% year-on-year, with average hospitalization costs around 8,000 yuan [3] - Despite the extensive coverage, basic medical insurance faces limitations due to fund constraints, leading to cost control measures that may reduce patient satisfaction [3][4] Group 2: Evolution of Commercial Medical Insurance - Commercial medical insurance is transitioning from a supplementary role to a core component of the medical security system, particularly with the rise of million medical insurance products that offer high coverage at low premiums [3][4] - Early million medical insurance products faced challenges such as renewal difficulties and high deductibles, impacting user experience [4] - Current market trends show that companies like ZhongAn Insurance and Ping An Health are developing mid-tier medical insurance and upgrading million medical insurance to include high-quality medical services [4] Group 3: Policy and Future Directions - The 2024 "National Ten Articles" for the insurance industry aims to include new medical technologies, drugs, and devices in the coverage of commercial insurance, enhancing its role in the multi-tiered medical security system [5] - Experts suggest that commercial health insurance should leverage risk-based pricing advantages and explore coverage for pre-existing conditions to fill gaps left by basic medical insurance [5][6] - The long-term vision for commercial health insurance is to take on a more significant role in medical security, addressing the increasing demand for better healthcare and diverse insurance products [6]

金十数据6月20日讯，2025年1-5月职工医保个人账户共济人次1.67亿，金额220.26亿元。通过即时调用 被绑定人个人账户方式进行职工医保个人账户省内共济的人次1.67亿，共济金额219.82亿元。通过医保 钱包转账方式进行职工医保个人账户省内、跨省共济共6.42万笔，转账金额4370.31万元。 （国家医保 局） 1-5月职工医保个人账户共济人次1.67亿，共济金额220.26亿元 ...

浙江寿仙谷医药股份有限公司相 信用评级报告声明 除因本次评级事项本评级机构与评级对象构成委托关系外，本评级机构及评级从业人员与评级对象不存 在任何足以影响评级行为独立、客观、公正的关联关系。 本评级机构与评级从业人员已履行尽职调查义务，有充分理由保证所出具的评级报告遵循了真实、客 观、 公正原则，但不对评级对象及其相关方提供或已正式对外公布信息的合法性、真实性、准确性和完整性 作任何保证。 本评级机构依据内部信用评级标准和工作程序对评级结果作出独立判断，不受任何组织或个人的影响。 本评级报告观点仅为本评级机构对评级对象信用状况的个体意见，不作为购买、出售、持有任何证券的 建议。本评级机构不对任何机构或个人因使用本评级报告及评级结果而导致的任何损失负责。 本次评级结果自本评级报告所注明日期起生效，有效期为被评证券的存续期。同时，本评级机构已对受 评对象的跟踪评级事项做出了明确安排，并有权在被评证券存续期间变更信用评级。本评级机构提醒报 告使用者应及时登陆本公司网站关注被评证券信用评级的变化情况。 本评级报告版权归本评级机构所有，未经授权不得修改、复制、转载和出售。除委托评级合同约定外， 未经本评级机构书面同意， ...

据悉，为保障医保政策落地见效，呼和浩特市医疗保障局明确，各级医疗机构需严格执行医保政策 规定，健全内部管理制度，严格遵循基本医疗保险"三个目录"，杜绝过度诊疗、串换药品等违规行为， 确保医保基金使用规范高效，切实维护参保群众的合法权益。 此次政策调整，旨在进一步优化医保资源配置，让参保居民在基层就医时能够享受更高额度的医疗 费用报销，减轻群众医疗负担。同时，为保障医保基金安全、合理使用，各级医疗保障部门将强化监管 力度，健全智能监管知识库、规则库，针对异常结算数据及时预警，严厉打击欺诈骗保行为。 6月18日，呼和浩特市医疗保障局发布消息，为满足参保群众就医购药需求，提升基层医疗机构服 务能力，促进分级诊疗，呼和浩特市出台城乡居民门诊统筹利好政策：自7月1日起，将社区卫生服务中 心、乡镇卫生院城乡居民门诊统筹支付限额由原标准上调至1200元。 ...

Group 1 - Fujian Quanzhou has launched an instant settlement model for basic medical insurance funds to improve settlement efficiency and alleviate financial pressure on designated medical institutions [1] - The instant settlement reform establishes an efficient mechanism of "daily payment + monthly settlement" by compressing the settlement cycle and increasing payment frequency [1] Group 2 - Shanghai Pharmaceuticals announced that its subsidiary in Thailand received approval from the Thai FDA for the registration of Pregabalin capsules, which are used to treat various types of neuropathic pain and as an adjunct therapy for epilepsy [3] - Gilead Sciences announced that the FDA approved its injectable HIV-1 capsid inhibitor Yeztugo for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection in adults and adolescents weighing 35 kg or more [4] Group 3 - Haizheng Pharmaceutical plans to establish a joint venture for synthetic biology with its wholly-owned subsidiary, with a registered capital of 350 million yuan, aiming to support the professional and large-scale development of its synthetic biology business [6] - Nuo Vision announced a plan to repurchase shares worth between 5 million and 10 million yuan for employee stock ownership plans, with a repurchase price not exceeding 30 yuan per share [7] - Tiankang Biological's subsidiary Tiankang Pharmaceutical has completed the counseling acceptance for its public stock issuance and listing on the Beijing Stock Exchange [8] Group 4 - Baike Biological received approval from the National Medical Products Administration for clinical trials of its influenza virus split vaccine, which aims to provide new vaccination options for individuals aged 60 and above [10] - Dizhi Pharmaceutical announced the completion of patient enrollment for its global Phase III clinical study of its lung cancer targeted drug, which compares its drug with platinum-based chemotherapy for advanced non-small cell lung cancer [11] Group 5 - The FDA announced the launch of the "Commissioners National Priority Voucher" program to expedite new drug review times from approximately 10-12 months to 1-2 months for eligible companies [12] - Shengnuo Biological expects a net profit increase of 254% to 332% year-on-year for the first half of 2025, driven by strong performance in its peptide raw material business [12]